The UK population is set to grow by five million people in 10 years, despite death rates being projected to overtake birth rates in that time. All of the forecast population growth is due to ...

Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000–19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World ...

The U.S. population grew by 1% during that time period, largely driven by international migration. It was the fastest rate of growth since 2001, according to the Census Bureau. Nevada was the ...

This follows a 2% decline in 2024. Optimistic signs are slowly becoming visible. Monthly construction volume data was already showing some growth in October and November last year. House prices of ...

But is Europe ready? By Jeanna Smialek Jeanna Smialek covers the European Union and reported this story from the World Economic Forum’s annual conference in Davos, Switzerland. Jan. 21 ...

Despite facing a whole raft of its own domestic difficulties - not least in leading EU countries, Germany and France - Europe has been ... economic growth is sluggish and politics are volatile.

Opportunities also arise in the field of drinking water, as population growth and climate change lead to more frequent dry periods in many places; we need more waterworks! Engineering developments are ...

Major economies are heading toward a "population collapse ... including Europe and the U.S., with immigration "accounting for most of the growth" expected in the U.S. this year, William Frey ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Do you have a tip on a science story that Newsweek should be covering? Do you have a question about population growth? Let us know via [email protected].

Takeda CEO Christophe Weber took to the stage to explain the company's growth plans despite Entyvio's future downfall. Takeda has 6 mid- and late-stage drugs that could generate up to $20 billion ...